Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
PRESS RELEASE For immediate release Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment. Quebec - May 16th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) today announced that the Canadian...
Devonian Announces Grant of Options
PRESS RELEASE For immediate release Devonian Announces Grant of Options. QUEBEC, Québec - March 21st, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) announces that the Board of Directors has approved the grant of options (the...
Devonian announces the trading of its shares will resume on Tuesday February 27th, 2018
PRESS RELEASE For immediate release Devonian announces the trading of its shares will resume on Tuesday February 27th, 2018 QUEBEC, February 23rd, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) is pleased to announce that it has...
Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.
Source: Aspri Pharma Canada Inc. February 07, 2018 09:57 ET Amended News Release - Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc. CONCORD, Ontario, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc....
Devonian Announces Acquisition of Altius Healthcare
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release Devonian Announces Acquisition of Altius Healthcare Transaction highlights: Provide Devonian sales and marketing benchstrength Create a compelling financial and operational platform...
Devonian Announces voting results of the Annual General and Special Meeting
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release Devonian Announces voting results of the Annual General and Special Meeting Quebec, Quebec – January 15, 2018 –Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV:...
Devonian Announces the Filing of New Patent Application for ThykamineTM
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Devonian Announces the Filing of New Patent Application for ThykamineTM Quebec, Quebec –...
Devonian Announces Initiation of Phase IIa Clinical Trial of ThykamineTM in Adult patients with Mild-to-Moderate Atopic Dermatitis
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Devonian Announces Initiation of Phase IIa Clinical Trial of ThykamineTM in Adult patients with...
Devonian Health Announces PurgenesisTM anti-aging treatment marketing and distribution partnership.
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Devonian Health Announces PurgenesisTM anti-aging treatment marketing and distribution...
Devonian Health Group to present at GCFF (Global Chinese Financial Conference) 18th annual conference
DEVONIAN HEALTH GROUP INC. PRESS RELEASE For immediate release NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Devonian Health Group to present at GCFF (Global Chinese Financial Conference) 18th annual conference. Quebec,...